Transcriptome analysis profile to understand mechanisms activated by FDA molecules that overcome the ATP7B mediated resistance to cisplatin in ovarian cancer IGROV-CP20 cells.
Ontology highlight
ABSTRACT: Transcriptome analysis profile to understand mechanisms activated by FDA molecules that overcome the ATP7B mediated resistance to cisplatin in ovarian cancer IGROV-CP20 cells.
PROVIDER: PRJNA553517 | ENA |
REPOSITORIES: ENA
ACCESS DATA